ISSN # 1718-7028
Ce document est disponible en français.
For information, please contact:
Business Planning and Finance Branch
Ministry of Research and Innovation
Tel: (416) 325-6421
Fax: (416) 327-4239
Table of Contents
PART I: PUBLISHED RESULTS-BASED PLAN 2010-11 |
Page |
Ministry Overview |
2 |
Ministry Mandate |
2 |
Ministry Key Initiatives |
3 |
Ministry Contribution to Key Priorities and Results |
5 |
Ongoing Ministry Activities |
6 |
Looking Ahead |
10 |
Legislation |
11 |
Performance Measure |
12 |
Ministry Organization Chart |
13 |
Agencies, Boards and Commissions |
14 |
MINISTRY FINANCIAL INFORMATION |
|
Table 1: Ministry Planned Expenditures 2010-11 |
16 |
Table 2: Operating and Capital Summary by Vote |
17 |
APPENDIX 1: ANNUAL REPORT FOR 2009-10 Table 1: Ministry Expenditures – 2009-10 |
18 22 |
GLOSSARY |
23 |
Innovation is key to creating a strong economy and rewarding jobs that families can depend on today and in the future. Fostering an innovation-driven, globally competitive economy is a priority for the province and a vital component of the Open Ontario Plan.
Launched in 2005, the Ministry of Research and Innovation (MRI) is focused on strengthening Ontario as a leading, innovation-based economy and society where innovative thinkers can flourish and innovative ideas are rewarded. The Ministry invests in and supports research, innovation and commercialization projects and partnerships across the province, collaborating with colleges, research hospitals, universities, private sector entities and other governments.
The Ministry mandate is to foster a culture of innovation and showcase Ontario, nationally and internationally, as a place where innovation is happening.
"It's encouraging to see the long-term commitment to excellence in both basic and applied research. This gives us the foundation for the great discoveries of the future." Dr. John Evans, Chair Emeritus, MaRS Discovery District |
Strategic Direction: Ontario’s Innovation Agenda
In April 2008, MRI launched the $3.2 billion Ontario Innovation Agenda, a strategy to make innovation a driving force of the Ontario economy. The agenda lays the foundation to implement and deliver flagship government initiatives that support a strong, innovative economy and good jobs for Ontario families.
Key elements of the agenda are:
Driving Forward Tomorrow’s Innovation Economy: Ministry Priorities
Ontario’s Innovation Agenda will guide the ministry’s investments and work in the following areas for 2010-11:
The Ontario Network of Excellence (ONE) is Ontario's revitalized, client-focused, province-wide innovation network. ONE also supports start-ups, emerging growth companies, small and medium-sized enterprises, and large domestic and multi-national enterprises — that wish to pursue innovation to create a global competitive advantage and new wealth in Ontario. |
Announced in 2009, the Ontario Network of Excellence (ONE) will play a critical role in helping Ontario implement its $3.2 billion innovation agenda and ensure that made-in-Ontario innovations have every opportunity to generate new products and services, new businesses, new companies and new jobs in this province.
In 2010, the ministry will work with MaRS Discovery District and the Ontario Centres of Excellence to further develop the ONE network. The ministry will also select the innovation centres across Ontario that will function as the primary service delivery agents for ONE clients. The ONE Advisory Board – which will ensure the overall effectiveness and efficiency of the network - will be selected this year.
The programs and services of the ONE will include:
The 2010 Budget demonstrates Ontario’s continued commitment to innovation as a platform that supports the government’s Open Ontario plan to transform Ontario to an innovation-driven economy,
"Through initiatives like the Ontario Emerging Technologies Fund, this government answers an urgent need for access to capital to support innovation and entrepreneurship. The co-investment model works with the market to help Ontario's entrepreneurs start more companies and create more jobs in the province." Iain Klugman |
The ministry will continue to roll out the multi-year Ontario Innovation Agenda – and all programs will continue at the planned level.
In fact, MRI is planning to increase spending by $67 million in fiscal year 2010-11, a 19 per cent increase over the previous year, and will continue to make investments toward key priorities, such as the Ontario Research Fund, the Global Leadership Round in Genomics and Life Sciences, the Early Researcher Awards, the Ontario Venture Capital Fund and the Ontario Emerging Technologies Fund.

The Ontario Research Fund - Research Excellence program (ORF-RE) provides researchers with the support to undertake cutting-edge research. It promotes research excellence in Ontario and contributes to enhancing Ontario’s business climate, skills and knowledge for innovation – while fostering and celebrating innovation through its outreach activities.
An ORF-RE investment of $6.5 million is supporting the Ontario Network for Advanced Medical Imaging Detectors at the Thunder Bay Regional Research Institute. The network will bring together researchers and industry to develop and commercialize a revolutionary, new generation of imaging devices for a variety of biomedical applications. These devices will lead to the detection and diagnosis of medical problems accurately and at the earliest stage of a disease, which is critical for effective treatment and recovery. |
Since 2006-07, MRI invested $368.6 million in ORF-RE to support 91 leading-edge research projects across the province, leveraging $730.8 million from over 450 industry, institutional and federal partners.
Through ORF-RE, a special Global Leadership Round in Genomics and Life Sciences (GL2) competition was held in 2009-10 to support basic and applied genomics and gene-related research at Ontario’s universities, hospitals and other research institutions.
GL2 supports the creation of new knowledge to drive innovation by focusing investments in leading-edge, large-scale genomics and gene-related research initiatives.
In April 2010, MRI announced an investment of over $115 million in 19 leading-edge research projects. Researchers on these projects are working to discover new therapies and technologies that will help people live healthier lives, as well as protect the environment and biodiversity.
The Ontario Research Fund – Research Infrastructure program (ORF-RI) ensures researchers have the funds to invest in state-of-the art equipment and facilities. By providing researchers with access to necessary equipment, Ontario research institutions are able to attract the best talent and create essential capacity to conduct world-leading research.
Since 2004-05, MRI has committed approximately $571 million to cover the infrastructure costs of 1,165 leading-edge research projects across the province. ORF-RI is also leveraging nearly $1.4 billion from the federal government and institutional partners.
In 2009-10, OICR's Intellectual Property Development and Commercialization Program funded thirteen projects (10 existing and 3 new investment) that transform laboratory research into clinical applications for a total investment of $2.95 million in 09-10. There were 2 new companies established during the year. |
The Ontario Institute for Cancer Research (OICR) is an MRI-funded, independent, not-for-profit organization undertaking ground-breaking research into the causes and treatments of cancer. In total, MRI is investing $357 million over OICR’s first five years to support the operating and capital costs of OICR.
The International Cancer Genome Consortium (ICGC) Partnership with Ontario is creating an international collaboration between the Ontario Institute for Cancer Research (OICR) and the ongoing global network of scientists leading the fight against cancer by coordinating the work of scientists around the world. To make this collaboration a reality, MRI invested $40 million in OICR to collect research data and share it with scientists worldwide. Genetic information derived from cancer cells will help identify better ways to kill tumours and tailor treatment to specific cancer types. 18 funding agencies in 10 countries and the European Union have now officially launched ICGC projects and committed approximately $400 million in funding. This project will be a magnet for other investments and create jobs for more than 50 researchers in Ontario.
Through the Innovation Demonstration Fund, the province is contributing $3.6 million to Group IV Semiconductor Inc. (Group IV), an Ottawa-based company, to help expand its fabrication facility at Carleton University and complete technology development. The company's technology could lead to low-cost light bulbs that will use up to 90 per cent less electricity than regular bulbs and last much longer, significantly cutting greenhouse gas emissions and reducing the waste burdon on landfills. Currently the company employs 25 people and expects to increase the number to 44 over the next two years. |
The Innovation Demonstration Fund (IDF) was announced in 2006 to help companies develop promising bio-based environmental and alternative-energy technologies. To date, MRI has funded 15 innovative Ontario companies which will lead the next generation of innovative projects such as water current-power energy generation and new solar panel technologies. The 2009 Ontario Budget included an enhancement of $50 million over four years to the Innovation Demonstration Fund.
The Ontario Emerging Technologies Fund (OETF) is a direct investment fund established by the Province of Ontario in 2009. The Government has announced that the OETF will be a $250 million fund to co-invest alongside qualified investors into innovative, high-growth, private Ontario companies. The fund is managed by the Ontario Capital Growth Corporation (OCGC), an agency of the Ontario Ministry of Research and Innovation. To date, the Ontario Capital Growth Corporation, through the OETF, has approved investments of approximately $9 million in four Ontario-based technology companies: Avvasi Inc., Bearing Media Inc., ecobee Inc., and EnviroTower
Ontario Venture Capital Fund (OVCF) - In 2007-08, Ontario secured commitments from the Ontario Municipal Employee Retirement System (OMERS), the Royal Bank of Canada, the Business Development Bank of Canada and Manulife Financial to lever Ontario’s $90 million initial investment into a $205 million Ontario Venture Capital Fund. Ontario’s funds are held by the Ontario Capital Growth Corporation. The Fund is managed by Northleaf Capital (formerly TD Private Equity) on behalf of the limited partners, including Ontario. To date, the OVCF’s Fund Manager, Northleaf Capital, is proceeding with investments totalling almost $60 million into three Ontario-based funds run by Georgian Partners, XPV Capital Corporation, and Lumira Capital. The OVCF has also and made two direct co-investments into Ontario companies: I Love Rewards and BlueCat Networks.
The Ontario Tax Exemption for Commercialization was announced in 2008 to support newly established corporations in priority areas by encouraging the commercialization of intellectual property developed at qualifying Canadian universities and colleges. The program offers a refund of corporate income tax and corporate minimum tax paid for a qualifying corporation’s first ten taxation years.
Ontario Network of Excellence (ONE) - In June of 2009, the Minister of Research and Innovation outlined a new vision for accelerating the growth of innovative companies in Ontario. Under the re-vitalized network there are:
The Business Eco-System Support Fund supports sophisticated industry – academic partnerships that will accelerate product development in emerging global markets. In 2009/10 and early 2010/11, the ministry launched 4 new innovation centres:
Research aimed at supporting sustainable environmental management of our freshwater ecosystems, harnessing new energy while reducing our carbon footprint, and protecting Ontarians relying on groundwater for their drinking water supply are among 14 bio-economy and clean technologies research projects that received support from the provine's Early Researcher Awards program. |
Research Talent Awards - The ministry continues to recognize achievement through its Research Talent Awards programs such as the Premier’s Catalyst Awards ($2.8 million to 14 innovative companies since 2007) and the Premier’s Discovery Awards ($4.75 million to 13 top researchers since 2007). The Premier’s Summit Awards, funded by MRI and administered by MaRS, provides awards for medical research ($20 million to 8 winners since 2007).
Early Researcher Awards - To date, MRI has provided $58.7 million to 419 newly appointed researchers to help them build their teams and support them early in their careers. Each researcher receives up to $140,000 from MRI, with a $50,000 match by the researcher’s institution. Since 2003, Early Researcher Awards winners have used 1% of their awards to engage over 24,000 youth through 544 outreach events.
Post-Doctoral Fellowships - MRI has provided $9.8 million in Post-Doctoral Fellowships to support 196 fellows across Ontario. The program recruits and retains outstanding young scientists to spend two years as post-doctoral fellows in Ontario research institutions. For each fellow, institutions receive $25,000 per year for two years from MRI, matched by the institution.
Youth Outreach Programs The ministry is supporting the next generation of researchers and innovators through its youth programs.
International Strategic Opportunities Program - The ministry will continue promoting Ontario’s Innovation – nationally and internationally – through the International Strategic Opportunities Program (ISOP). ISOP provides funding for strategic international collaborations between Ontario research institutions and the global research community. The goal of the program is to improve Ontario’s long-term economic potential by attracting and retaining the best and brightest research talent. Since 2005-06, ISOP has provided $2.8M in funding to support 20 international research collaborations.
Stem Cell Partnership with California - The Cancer Stem Cell Consortium, announced in May 2008 by Premier Dalton McGuinty, with a contribution of $30 million from the Ontario Institute for Cancer Research, is coordinating and funding cancer stem cell research carried out by Canadian and Californian researchers, universities and private industry. In 2009-10, this investment leveraged $80 million in additional funding from Genome Canada, the Canadian Institutes of Health Research, and the California Institute for Regenerative Medicine for OICR projects involving Canadian and Californian scientists working together on common cancer stem cell projects.
As the ministry moves through 2010-11, MRI will focus on implementing the Ontario Innovation Agenda and establish the Ontario Network of Excellence (ONE), continuing the success of ongoing programs and initiatives and delivering on program and legislative commitments.
The Ontario Capital Growth Corporation Act, 2008establishes the Ontario Capital Growth Corporation as a statutory corporation without share capital. The Act provides that the Corporation is an agent of the Crown in Right of Ontario. The Corporation fulfills Ontario’s legal obligations as a limited partner in the Ontario Venture Capital Fund.
Ontario Regulation 278/09 made under the Ontario Capital Growth Corporation Act, 2008 provides that the Corporation acquire, manage and otherwise deal with a portfolio of investments in businesses that the Corporation considers constitute emerging technology businesses. This portfolio is known in English as the Ontario Emerging Technologies Fund.
The Ontario Tax Exemption for Commercialization, administered jointly by MRI and the Ministry of Revenue, is a legislated program under the Corporations Tax Act and the Taxation Act, 2007. The Acts are the responsibility of the Ministry of Finance.
The Leveraged Investment in Innovation performance measure provides information on the expected partner and matching investments in research and commercialization initiatives that the ministry provides funding for. It is a significant indicator as it illustrates the role that the ministry plays as a facilitator and generator of investments and participation by the private sector, the federal government and other parties in Ontario's research and commercialization initiatives.
Leveraged investment targets have been consistently exceeded each year. In 2008-09 leveraged investment was $526 million, $82 million more than in 2007-08, and $201 million above target.


Operating Agency
Ontario Capital Growth Corporation
The Ontario Capital Growth Corporation (OCGC or the Corporation) was established by the Ontario Capital Growth Corporation Act, 2008. The Act was proclaimed and in force as of February 1, 2009. The interim Board of Directors is comprised of public servants, who were appointed by the Lieutenant Governor in Council on February 4, 2009.
The OCGC is an agent of the Crown and is classified as an operational enterprise agency. Under the Act, the Corporation’s principal activities are to:
Additional objects of the Corporation were added later in 2009 through Ontario Regulation 278/09 made under the Ontario Capital Growth Corporation Act, 2008.
The Corporation’s fiscal year commences on April 1 in each year and ends on March 31 in the following year. The Board will submit an annual report on its affairs (including audited financial statements) to the Minister of Research and Innovation within 90 days after the end of each fiscal year.
Advisory Agencies
Ontario Research Fund Advisory Board
The Ontario Research Fund Advisory Board is an advisory board that adjudicates applications to Ontario's research programs, which fund research talent, infrastructure and operations. The Board makes recommendations to the Minister based on a project's merit and alignment with the respective program's goals and provides advice and assistance to the Minister as required. The Board adjudicates applications for the Ontario Research Fund, the Early Researcher Awards (ERA) Program, the
Premier's Discovery Awards (PDA) Program and the Premier's Catalyst Awards (PCA) Program. The ORF provides infrastructure, operating and overhead funds to support leading edge R&D in Ontario’s research institutions. The ERA supports early career researchers with recognized potential. The PDA celebrates the research excellence of Ontario's top researchers and the PCA recognizes Ontario's top innovative entrepreneurs and companies.
Ontario Network of Excellence Advisory Board
In 2009-10, the ministry created the Ontario Network of Excellence Advisory Board as part of the revitalized Ontario Network of Excellence. The Board will provide advice to ensure that Ontario’s sophisticated network of delivery partners and company acceleration programs is one of the best in the world operates with maximum efficiency and is focused on getting results – ensuring Ontario companies can get their innovative products to markets around the world.

Program Name |
Ministry Planned Expenditures ($M) |
Operating Expense * |
|
Ministry Administration |
5.3586 |
Science and Research |
197.2942 |
Innovation and Commercialization |
163.1176 |
Total Operating Expense * |
365.7714 |
Capital Expense * |
89.9980 |
Total Operating and Capital Expense, Excluding Assets * |
455.7694 |
Operating Assets |
7.8490 |
Capital Assets |
0.0010 |
*Excludes Consolidation Adjustments
The ministry focuses its efforts on activities which support a stronger Ontario in the creation of jobs in today's and future economies by: implementing research and innovation policies and programs based on expert advice to ensure an agenda to deliver excellence, performance and results; working closely with our partner ministries to implement programs to achieve future social, environmental and economic benefits; and fostering a culture of innovation and showcasing Ontario, nationally and internationally, as an innovation-based economy and society.
The ministry's key priorities are: extracting value from Ontario's excellence in research and commercialization; focusing investment in areas where Ontario can be globally competitive; leveraging skills, knowledge, and funding; developing an innovation-friendly business climate; and enhancing the Ontario government's role as a catalyst for change.
The Ministry of Research and Innovation (MRI) places a clear focus on the government’s commitment to innovation as a catalyst for economic growth across all sectors of the economy.
Highlights of Achievements
Highlights from the 2009-10 period include:
Setting the Stage for Innovation in Ontario: The Ontario Innovation Agenda
Ontario is investing in an aggressive innovation agenda to ensure we are one of the winning economies in the 21st century. Supported by close to $3.2 billion in spending over eight years and a focus on seizing global market opportunities, this agenda builds on the strength of Ontario’s creative environment, diverse culture, highly skilled workforce, world-class education system and internationally recognized research community.
The focus of the agenda is to ignite growth in the industries that will shape our future and create Ontario’s next generation of jobs and prosperity. It builds on this province’s greatest strength – the talent and ingenuity of our people. The agenda advocates:
Driving Forward Tomorrow’s Innovation Economy: Priority Areas
The innovation agenda will guide investments in areas where Ontario is or will be identified as a global leader. Initial areas of focus include the bio-economy and clean technologies, advanced health technologies, pharmaceutical research and manufacturing, and digital media and information and communications technologies.
2009-10 investments:
Supporting the Next Generation of Jobs Fund
MRI is also supporting the government’s Next Generation of Jobs Fund – jointly administered with the Ministry of Economic Development and Trade (MEDT) – which represents the government’s strong commitment to focused investment in areas where Ontario can lead globally.
The Biopharmaceutical Investment Program, part of the Next Generation of Jobs Fund, has invested in five projects to date, totalling $26.5 million and creating 195 new permanent jobs in addition to 400 short-term construction positions at five world-leading companies Therapure, Merck, Pfizer, Purdue Pharma, and Sanofi-Pasteur.
Building a Robust Post-Secondary Research Environment
Under the fourth round of the Ontario Research Fund (ORF) – Research Excellence program, MRI invested nearly $69.5 million to support 21 leading-edge research projects across the province.
In 2009-10 MRI invested nearly $262 million through the Ontario Research Fund – Research Infrastructure program to support 214 research infrastructure projects across the province.
MRI also invested over $114 million to support 19 leading-edge research projects across the province through a special Genomics and Life Sciences competition (GL2) that provides an opportunity for the province to fund truly transformative research and build on an area where Ontario researchers have demonstrated world-leading strength
The ministry continues to support ground-breaking research into the causes and treatments of cancer through the Ontario Institute for Cancer Research. In total, MRI is investing $357 million over OICR’s first five years.
Enhancing Ontario’s Capacity to Bring Ideas to the Marketplace
In 2009-10, MRI continued to support the commercialization of research, and continued to deliver existing research and commercialization programs effectively, including:
Growing the Next Generation of Researchers and Innovators
Promoting Ontario’s Innovation – Nationally and Internationally
Ministry Key Performance Results 2008-09
MRI performance results for its three key measures for 2008-09:
|
Ministry Interim Actual Expenditures ($M) |
Operating |
$272.5M |
Capital |
$71.3M |
Staff Strength (as of March 31, 2010) |
145 |
BAP |
Business Acceleration Program |
CEA |
Communication Enabled Applications |
ERA |
Early Researcher Awards |
HTX |
Health Technology Exchange |
GL2 |
Global Leadership Round in Genomics and Life Sciences |
IACP |
Industry-Academic Collaboration Program |
ICGC |
International Cancer Genome Consortium |
IDF |
Innovation Demonstration Fund |
ISOP |
International Strategic Opportunities Program |
MaRS |
MaRS Discovery District |
MAT |
Medical & Assistive Technologies |
MEDT |
Ministry of Economic Development and Trade |
MRI |
Ministry of Research and Innovation |
OCE |
Ontario Centres of Excellence |
OCGC |
Ontario Capital Growth Corporation |
OCN |
Ontario Commercialization Network |
ODOE |
Other Direct Operating Expenditures |
OICR |
Ontario Institute for Cancer Research |
OETF |
Ontario Emerging Technologies Fund |
OMERS |
Ontario Municipal Employee Retirement System |
ONE |
Ontario Network of Excellence |
ONEAB |
Ontario Network of Excellence Advisory Board |
ORF |
Ontario Research Fund |
ORF-RE |
Ontario Research Fund – Research Excellence |
ORF-RI |
Ontario Research Fund – Research Infrastructure |
OTEC |
Ontario Tax Exemption for Commercialization |
PCA |
Premier's Catalyst Awards |
OVCF |
Ontario Venture Capital Fund |
PDA |
Premier's Discovery Awards |
Post-Doctoral Fellowship |
|
R&D |
Research and Development |
RIC |
Regional Innovation Centre |
SIC |
Sector Innovation Centre |
SME’s |
Small and Medium-Sized Enterprises |
TSTOP |
Teacher's Science and Technology Outreach Program |
YSTOP |
Youth Science and Technology Outreach Program |